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Associate Editor at Biomedical JournalThis issue of Biomedical Journal includes two review articles
on natural killer T cells. The first review article has been
written by Drs. Birkholz and M. Kronenberg: « Antigen Speci-
ficity of Invariant Natural Killer T Cells » [1]. The second review
is from Dr Agnes Lehuen and her colleagues on « Regulatory
Role of Natural Killer T Cells in Diabetes » [2].
Dr Kronenberg's review principally describes the ligands of
natural killer T-cells (iNKT) bearing a T cell receptor (TCR)
comprising an invariant TCR alpha-chain associated with a
limited number of V-beta chains. It analyzes in depth the lipid
antigens which are presented by the weakly polymorphic
CD1d molecule, structurally similar to MHC class I molecules.
The mode of interactions of alpha-galactosylceramide
(alphaGalCer) with CD1d and the invariant TCR are
described. Several head group modifications of the alpha-
GalCer sugarmoiety have been shown to alter TCR binding and
iNKT responses. Indeed, some synthetic compounds related to
alphaGalCer were inactive while others were shown to pref-
erentially trigger Th1 or Th2 iNKT responses. Modifications of
lipid chains of CD1d agonists lead to the synthesis of new
antigens with Th2 or Th1 profiles. Stronger interactions of
these modified agonists with CD1d and/or prolonged presen-
tation of them by dendritic cells triggered higher IFN-gamma
production in vivo. This resulted in a stronger adjuvant effect
when compared to regular alphaGalCer. Other parts of this
review are devoted to the structural analyses of endogenous
ligands and foreign antigens from bacteria, fungi and para-
sites. Isoglobotrihexosylceramide, the first self-ligand to be
identified, is shown complexed to mouse CD1d and mouse
iNKT TCR in a crystal structure. Numerous microbial antigens
recognized by iNKTTCRs are glycolipids capable of stimulating
protective immune responses against pathogens. This very
interesting review clearly shows that deciphering the
biochemical rules of interactions in the various tri-molecular
CD1d-antigen-INKT TCR complexes, is likely to lead to the
synthesis of agonists with therapeutic values.E-mail address: jean.kanellopoulos@u-psud.fr.
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evidence demonstrating that iNKT cells are implicated in the
control of type 1 diabetes in NOD mice. The number of iNKT
cells isdecreased inNODmiceandwhile thesecells secrete IFN-
gamma, their IL-4 production is much lower than in control
animals. The authors describe their own experiments which
show that iNKT lymphocytes are able to induce anergy of
autoreactive T cells and/or inhibit the production of IFN-
gamma by the remaining pathogenic T lymphocytes. Interest-
ingly, they showed that iNKT cells are able to stimulate the
expansion of regulatory T lymphocytes by converting naive
diabetogenicT cells into regulatoryTcells. Theauthorsdescribe
the complex interactions between various cell populations and
the secretion of multiple cytokines involved simultaneously in
the control of viral infection and the induction of tolerance to
pancreatic beta-cells. Interestingly, the authors present results
from the literature showing that a subpopulation of iNKT
lymphocytes (CD4, NK1.1) synthesizes high levels of IL-17
and small amounts of IL-4 and IFN-gamma. These iNKT 17
lymphocytes increase the incidence of diabetes in NOD mice.
Finally, the impact of microbiota on type 1 diabetes and host
metabolisms is discussed in the context of iNKT cells and lipid
antigens. In the last paragraph, the authors analyze recent data
suggesting that iNKT are also involved in protection against
type 2 diabetes, restore insulin sensitivity and decrease body
fat. This stimulating review summarizes our present knowl-
edge on iNKT cell role in protection against diabetes and shows
the complexity of the protective mechanisms involved.r e f e r e n c e s
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